BTG3 and systemic lupus erythematosus: The serum level of the altered protein for a novel biomarker in SLE patients was compared to healthy controls by Western blot analysis, which determined the correlation with a titer of anti-nuclear antibody (ANA) testing, diagnostic performance with sensitivity and specificity values by statistical investigation.